BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16316460)

  • 1. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
    Mathew J; Leong MY; Morley N; Burt AD
    BMC Dermatol; 2005 Nov; 5():12. PubMed ID: 16316460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
    Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
    J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
    Mathew J; Igbokwe UO; Morley N; Burt AD
    Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
    Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
    Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
    Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
    Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
    Bray AP; Barnova I; Przemioslo R; Kennedy CT
    Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.